Sofosbuvir/Velpatasvir/Voxilaprevir Salvage Therapy in Hepatitis C Patients Who Relapsed After DAA Treatment
NCT07565948
·
clinicaltrials.gov ↗
ACTIVE_NOT_RECRUITING
Status
200
Enrollment
OTHER
Sponsor class
Conditions
Hepatitis C Virus (HCV)
Sponsor
Xiangya Hospital of Central South University